Patent · US Active

Method of treating scoliosis using a biological implant to scoliosis

US9623152B2 · kind B2 · utility

4Cited by

18References

20Claims

0Family size

Inventors

James W. Ogilvie · Minneapolis, US
Kenneth Ward · Salt Lake City, US
Lesa M. Nelson · Park City, US

Key dates

Filing date	Jun 20, 2016
Grant date	Apr 18, 2017
Priority date	—
Expiry date	Jun 20, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2430/38
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

The present invention is a bone growth stimulating and promoting cytokine type biological implant preferably comprising PTH coated with a controlled release biodegradable coating that is implanted preferably in the concave side of a scoliotically curved spine in combination with a bone growth inhibiting type biological implant preferably comprising methotrexate or like anti-metabolite coated with a controlled release biodegradable coating that is implanted preferably in the convex side of a scoliotically curved spine. The insertion of the biological implant is highly non-invasion, especially as compared to more conventional spine surgical methods, and the biological implant does not decrease spinal mobility or spinal range of motion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.